Acrivon Therapeutics, Inc. short interest in 2023
In 2023, Acrivon Therapeutics, Inc.'s disclosed short interest ran from 0.33% of shares outstanding on 13 Jan 2023 to 1.43% on 29 Dec 2023, a change of +1.10 percentage points. The year's high was 1.90% on 31 Mar 2023 and its low 0.31% on 31 Jan 2023, averaging 1.33% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 47.41 days on 29 Sep 2023. Full history: Acrivon Therapeutics, Inc..
Cite this page
By year: 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 0.33% (13 Jan 2023)
- End of year
- 1.43% (29 Dec 2023)
- Change
- +1.10 pp
- High
- 1.90% (31 Mar 2023)
- Low
- 0.31% (31 Jan 2023)
- Average
- 1.33%
- Highest days to cover
- 47.41 (29 Sep 2023)
- SEC filings marked
- 10
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 0.33% | 6.60 | |
| 31 Jan 2023 | 0.31% | 11.11 | |
| 15 Feb 2023 | 0.32% | 1.49 | |
| 28 Feb 2023 | 0.48% | 1.81 | |
| 15 Mar 2023 | 0.93% | 2.31 | results (8-K) |
| 31 Mar 2023 | 1.90% | 1.95 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 1.87% | 10.34 | |
| 28 Apr 2023 | 1.88% | 20.19 | |
| 15 May 2023 | 1.85% | 15.16 | results (8-K), 10-Q filed, results (8-K) |
| 31 May 2023 | 1.74% | 17.96 | |
| 15 Jun 2023 | 1.64% | 13.35 | |
| 30 Jun 2023 | 1.65% | 6.37 | |
| 14 Jul 2023 | 1.58% | 29.68 | |
| 31 Jul 2023 | 1.53% | 19.56 | |
| 15 Aug 2023 | 1.50% | 25.66 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 1.46% | 36.30 | |
| 15 Sep 2023 | 1.46% | 17.52 | |
| 29 Sep 2023 | 1.44% | 47.41 | |
| 13 Oct 2023 | 1.38% | 15.12 | |
| 31 Oct 2023 | 1.39% | 12.83 | |
| 15 Nov 2023 | 1.31% | 11.31 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 1.28% | 12.32 | |
| 15 Dec 2023 | 1.32% | 6.11 | |
| 29 Dec 2023 | 1.43% | 11.12 |
See also: Acrivon Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.